International Journal of Nanomedicine (May 2019)

A nano-sized blending system comprising identical triblock copolymers with different hydrophobicity for fabrication of an anticancer drug nanovehicle with high stability and solubilizing capacity

  • Hoang NH,
  • Sim T,
  • Lim C,
  • Le TN,
  • Han SM,
  • Lee ES,
  • Youn YS,
  • Oh KT

Journal volume & issue
Vol. Volume 14
pp. 3629 – 3644

Abstract

Read online

Ngoc Ha Hoang,1,* Taehoon Sim,1,* Chaemin Lim,1 Thi Ngoc Le,1 Sang Myung Han,1 Eun Seong Lee,2 Yu Seok Youn,3 Kyung Taek Oh11College of Pharmacy, Chung-Ang University, Dongjak-gu, Seoul 06974, Korea; 2Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 14662, Korea; 3School of Pharmacy, Sungkyunkwan University, Suwon City 16419, Korea*These authors contributed equally to this workBackground: A very common and simple method (known as the blending method) to formulate drug delivery systems with required properties is to physically mix amphiphilic block copolymers with different hydrophobicity. In addition to its simplicity, this blending strategy could help avoid the time and effort involved in the synthesis of block copolymers with the desired structure required for specific drug formulations.Purpose: We used the blending strategy to design a system that could overcome the problem of high hydrophobicity and be a good candidate for drug product development using PEG-PLA-PEG triblock copolymers.Methods: Two types of PEG-PLA-PEG triblock copolymers with similar (long) PLA molecular weights (MWs) and different PEG MWs were synthesized. The micellar formulations were prepared by blending the two block copolymers in various ratios. The size and stability of the blending systems were subsequently investigated to optimize the formulations for further studies. The loading properties of doxorubicin or paclitaxel into the optimized blending system were compared to that in mono systems (systems composed of only a single type of triblock copolymer). In vitro and in vivo anti-cancer effects of the preparations were evaluated to assess the use of the blending system as an optimal nanomedicine platform for insoluble anticancer agents.Results: The blending system (B20 system) with an optimized ratio of the triblock copolymers overcame the drawbacks of mono systems. Drug uptake from the drug-loaded B20 system and its anticancer effects against KB cells were superior compared to those of free drugs (doxorubicin hydrochloride and free paclitaxel). In particular, doxorubicin-loaded B20 resulted in extensive doxorubicin accumulation in tumor tissues and significantly higher in vivo anti-cancer effects compared to free doxorubicin.Conclusion: The blending system reported here could be a potential nanoplatform for drug delivery due to its simplicity and efficiency for pharmaceutical application.Keywords: blending system, block copolymer, triblock copolymer, drug delivery, nanomedicine, cancer

Keywords